anna hemnes

Associate Professor

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Anna Hemnes is an Associate Professor at Vanderbilt University Medical Center in the United States. Her research focuses on pulmonary hypertension, with recent publications investigating topics such as chronic thromboembolic pulmonary hypertension, circular RNA profiling, and the clinical characteristics of patients with pulmonary arterial hypertension. Dr. Hemnes also explores echocardiographic parameters and their associations with right ventricular function in relation to various pulmonary conditions.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

View details

Sue Duval

University of Minnesota

UNITED STATES

View details

Erika B. Rosenzweig

Professor of Pediatrics (in Medicine)

Columbia University Irving Medical Center

UNITED STATES

View details

Thenappan Thenappan

University of Minnesota

UNITED STATES

View details

JoAnn Lindenfeld

Vanderbilt University Medical Center

UNITED STATES

View details

Quanhu Sheng

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

anna hemnes

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Incidence of Right Ventricular Dysfunction in an Echocardiographic Referral Cohort

The Surgical Management of Chronic Thromboembolic Pulmonary Hypertension

Circular RNA Profiling Identifies circ5078 as a BMPR2 -Derived Regulator of Endothelial Proliferation and Stress Responses

Metabolomic Evidence of Biological Overlap with Heart Failure with Preserved Ejection Fraction in a Subset of Pulmonary Arterial Hypertension

Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity

Chest CT in Pulmonary Arterial Hypertension

Echocardiographic Parameters and Risk Prediction in Pulmonary Arterial Hypertension

Incidence and Clinical Associations with Phenotypic Drift from Pulmonary Arterial Hypertension to Combined Pre- and Post-capillary Pulmonary Hypertension

Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension

Right Ventricular Function, Inflammation, and the Gut Microbiome in Pulmonary Hypertension: A Translational Frontier

Correlates of Plasma NT‐proBNP/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial

Myeloid-Specific JAK2 Contributes to Inflammation and Salt Sensitivity of Blood Pressure

Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension

Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial

Obituary: John H. Newman, MD

Prostaglandin I2 Therapy Promotes Regulatory T Cell Generation in Patients with Pulmonary Arterial Hypertension

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension

Cardiometabolic Risk Factors Associated With Right Ventricular Function and Compensation in Patients Referred for Echocardiography

Reply to Yasuma et al.

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR)

Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure

Daily Step Counts Are Associated with Hospitalization Risk in Pulmonary Arterial Hypertension

Physical Activity and Its Association with Traditional Outcome Measures in Pulmonary Arterial Hypertension

Collaborators (10)

Joseph A. Hill

Suman Kundu

Robert Frantz

Kimberly Dunham-Snary

Richard Kronmal

Sue Duval

Erika B. Rosenzweig

Thenappan Thenappan

JoAnn Lindenfeld

Quanhu Sheng

Make your next move.